News

The company also granted the underwriter a 30-day option to purchase up to an additional 1.05 million shares of common stock. Goldman, Sachs & Company acted as the

This phase II study is an international, multi-center, randomized, double- blind, controlled study in patients with complicated skin and skin structure infections (cSSSI) presumed or proven to be

Fentora is indicated only for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying

The switches are formed by molecules called receptor tyrosine kinases (RTKs) that often are mutated and hyperactive in cancer cells. Since a number of kinase-blocking drugs are already

The Texas-based biopharmaceutical company said that its investigational new drug (IND) application for the US study of Proellex became effective on September 10, 2007. The first study conducted

The Phase I trial, which evaluated 66 obese and mildly obese volunteers, demonstrated clinically relevant reductions in body fat, energy intake and waist circumference. V24343 was generally well

Under the terms of the deal, Best Medical will purchase Nomos Corporation assets, including stock of Nomos subsidiaries, Nomos GmbH and Nomos China USA. The purchase price is

The company is planning to present the results evaluating HE3286 at the 2nd International Congress on Immune-Mediated Diseases being held in Moscow, Russia. The company is also presenting

The randomized trial enrolls 300 patients and expects to complete over a 12 to 16-month period. Depending on the rate of progression, an interim analysis is targeted for